Random chemistry as a new tool for the generation of small compound libraries: Development of a new acetylcholinesterase inhibitor

Journal of Medicinal Chemistry

Volumn 48, Issue 23, 2005, Pages 7496-7499

  Kapková, Petra ^a   Heller, Eberhard ^a   Unger, Matthias ^a   Folkers, Gerd ^b   Holzgrabe, Ulrike ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

(9 AMINO 5,6,7,8 TETRAHYDROACRIDIN 4 YL)METHANOL; CHOLINESTERASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG POTENCY; DRUG SCREENING; ELECTROSPRAY MASS SPECTROMETRY; FRACTIONATION; GAMMA IRRADIATION; IC 50; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

ACETYLCHOLINE; CHOLINESTERASE INHIBITORS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GAMMA RAYS; MAGNETIC RESONANCE SPECTROSCOPY; METHANOL; PYRIDINIUM COMPOUNDS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TACRINE; WATER;

EID: 28544442309     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm058041z     Document Type: Article

References (18)

1. Kubinyi, H. Strategies and Recent Technologies in Drug Discovery. Pharmazie 1995, 50, 647-662.
2. Höltje, H. D.; Folkers, G. Molecular Modeling. Basic Principles and Applications; VCH: Weinheim, Germany, 1996.
3. Marrone, T. J.; Briggs, J. M.; McCammon, J. A. Structure-Based Drug Design: Computational Advances. Annu. Rev. Pharmacol. 1997, 37, 71-90.
4. Eichler, J. Kombinatorische Chemie (Combinatorial Chemistry); Teubner Verlag: Stuttgart, Germany, 2003.
5. Hughes, I.; Hunter, D. Techniques for Analysis and Purification in High-Throughput Chemistry. Curr. Opin. Chem. Biol. 2001, 5, 243-247.
6. Bürgisser, E.; Folkers, G. Random Generation and Bio-Specific Selection of Chemical Compounds. PCT WO 94/29719, 1994.
7. Folkers, G.; Kessler, U.; Bürgisser, E. Thymine Derivatives That Possess Antiviral and Antitumoral Effects. PCT WO 00/73281, 2000.
8. Folkers, G.; Kessler, U. Random Chemistry: Look for the Unexpected. Curr. Drug Discovery 2003, 1-6.
9. Kessler, U. Random Synthesis and Biological Characterisation of Nucleosid Analogues. New Perspectives for Drug Discovery. Ph.D. Dissertation (ETHZ No. 13592), 2000.
10. Francotte, P.; Graindorge, E.; Boverie, S.; de Tullio, P.; Pirotte, B. New Trends in the Design of Drugs Against Alzheimer's Disease. Curr. Med. Chem. 2004, 11, 1757-1778.
11. Ibach, B.; Haen, E. Acetylcholinesterase Inhibition in Alzheimer's Disease. Curr. Pharm. Des. 2004, 10, 231-251.
12. Parihar, M. S.; Hemnani, T. Alzheimer's Disease Pathogenesis and Therapeutic Interventions. J. Clin. Neurosci. 2004, 11, 456-467.
13. 2 muscarinic allosteric modulators. Recept. Channels 2003, 9, 229-240.
14. Solubilities; General Notices; Pharmacopoiea Europea, Council of Europe, Strasbourg, France, 1997; p 186.
15. Ellman, G. L.; Courtney, D. K.; Andres, V.; Feather-Stone, R. M. A New and Rapid Colorimetric Determination of Acetylcholinesterase Activity. Biochem. Pharmacol. 1961, 7, 88-95.
16. Kapková, P.; Stiefl, N.; Sürig, U.; Engels, B.; Baumann, K.; Holzgrabe, U. Synthesis, Biological Activity, and Docking Studies of New Acetylcholinesetrase Inhibitors of the Bispyridinium Type. Arch. Pharm. Med. Chem. (Weinheim, Ger.) 2003, 336, 523-540.
17. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and Computational Approaches To Estimate Solubility and Permeability in Drug Discovery and Development Settings. Adv. Drug Delivery Rev. 1997, 23, 3-25.
18. Moore, J. A.; Kornreich, L. D. Direct Synthesis of 4-Aminoquinolines. Tetrahedron Lett. 1963, 20, 1277-1281.